No differences were observed according to the type of ONS [(i) hypercaloric, high-protein peptide-based ONS rich in MCT without fiber; (ii) hypercaloric, high-protein ONS enriched with HMB and FOS and (iii) hypercaloric, high-protein diabetes-specific ONS with high MUFA]. This evidence concerns the gene FOS and diabetes mellitus.